CLINICAL_TRIALS
trial_result
· 2016-03-03
Clinical Trial Update: Preference of Tegaserod vs. PEG 3350 in Patients With Constipation [Phase 4]
Summary
Phase 4 trial comparing tegaserod with polyethylene glycol 3350 for constipation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Constipation | Phase 4 | Status: COMPLETED